Paladin Labs Inc.

Paladin Labs Inc.

September 30, 2009 16:00 ET

Paladin to Present at BioContact Conference in Quebec City

MONTREAL,CANADA--(September 30, 2009) - Paladin Labs Inc.(TSX: PLB), a leading Canadian specialty pharmaceutical company,announced today that Jonathan Ross Goodman, President & CEO and JosephWalewicz, COO Paladin Biosciences and Vice President, Special Projects willpresent a corporate update at the BioContact Conference on Wednesday, October7, 2009 at 3:30 p.m. ET at the Chateau Frontenac, Place d'Armes room,Quebec City. A copy of the presentation will be available at

About Paladin Labs Inc.

PaladinLabs Inc., headquartered in Montreal, Canada, is a specialty pharmaceuticalcompany focused on acquiring or in-licensing innovative pharmaceutical productsfor the Canadian market. With this strategy, a focused national sales team andproven marketing expertise, Paladin has evolved into one of Canada's leadingspecialty pharmaceutical companies. Paladin's shares trade on the Toronto StockExchange under the symbol PLB. For more information about Paladin, please visitthe Company's web site at

This pressrelease may contain forward-looking statements and predictions. Theseforward-looking statements, by their nature, necessarily involve risks anduncertainties that could cause actual results to differ materially from thosecontemplated by the forward-looking statements. The Company considers theassumptions on which these forward-looking statements are based to be reasonableat the time they were prepared, but cautions that these assumptions regardingthe future events, many of which are beyond the control of the Company and itssubsidiaries, may ultimately prove to be incorrect. Factors and risks, whichcould cause actual results to differ materially from current expectations, arediscussed in the annual report as well as in the Company's Annual InformationForm for the year ended December 31, 2008. The Company disclaims any intentionor obligation to update or revise any forward-looking statements whether as aresult of new information or future events and except as required by law. Foradditional information on risks and uncertainties relating to theseforward-looking statements, investors should consult the Company's ongoingquarterly fillings, annual report and Annual Information Form and otherfillings found on SEDAR at

Contact Information